1. Home
  2. GSK vs BSX Comparison

GSK vs BSX Comparison

Compare GSK & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GSK plc (Each representing two)

GSK

GSK plc (Each representing two)

HOLD

Current Price

$54.49

Market Cap

96.1B

Sector

Health Care

ML Signal

HOLD

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$71.29

Market Cap

137.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSK
BSX
Founded
1715
1979
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
96.1B
137.8B
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
GSK
BSX
Price
$54.49
$71.29
Analyst Decision
Buy
Strong Buy
Analyst Count
2
20
Target Price
N/A
$109.15
AVG Volume (30 Days)
5.7M
14.9M
Earning Date
01-01-0001
05-06-2026
Dividend Yield
3.17%
N/A
EPS Growth
N/A
55.20
EPS
N/A
1.94
Revenue
N/A
$9,076,000,000.00
Revenue This Year
$6.81
$12.04
Revenue Next Year
$4.74
$10.48
P/E Ratio
$32.75
$37.64
Revenue Growth
N/A
12.49
52 Week Low
$32.38
$70.75
52 Week High
$61.70
$109.50

Technical Indicators

Market Signals
Indicator
GSK
BSX
Relative Strength Index (RSI) 40.77 31.55
Support Level $47.89 N/A
Resistance Level $60.37 $76.87
Average True Range (ATR) 0.86 1.74
MACD -0.89 0.33
Stochastic Oscillator 6.29 12.91

Price Performance

Historical Comparison
GSK
BSX

About GSK GSK plc (Each representing two)

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: